Ignite Creation Date:
2025-12-25 @ 3:21 AM
Ignite Modification Date:
2026-03-03 @ 8:41 AM
Study NCT ID:
NCT03899805
Status:
COMPLETED
Last Update Posted:
2025-08-28
First Post:
2019-04-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas
Sponsor:
Organization: